TomoTherapy Incorporated
TomoTherapy Incorporated, a leader in advanced radiation therapy solutions, is headquartered in the United States. Founded in 2002, the company has established itself within the medical technology industry, focusing on innovative cancer treatment systems. TomoTherapy is renowned for its unique TomoTherapy® system, which combines intensity-modulated radiation therapy (IMRT) with computed tomography (CT) imaging, allowing for precise targeting of tumours while minimising damage to surrounding healthy tissue.
With a strong presence in North America and expanding operations in international markets, TomoTherapy has achieved significant milestones, including the development of the first helical radiation therapy system. The company’s commitment to enhancing patient care and improving treatment outcomes has solidified its position as a trusted provider in the oncology sector, making it a notable player in the fight against cancer.
-12 vs industry average
TomoTherapy Incorporated’s score of 15 is lower than 32% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at TomoTherapy Incorporated?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for TomoTherapy Incorporated yet.
TomoTherapy Incorporated's reported carbon emissions
TomoTherapy Incorporated, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a merged entity, and its climate commitments and emissions data are inherited from its parent company, Accuray Incorporated.
As of now, there are no documented reduction targets or climate pledges from TomoTherapy. The lack of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of formalising its climate strategy.
In the context of the industry, it is essential for companies like TomoTherapy to establish clear climate commitments and reduction targets to align with global sustainability goals. The absence of such data highlights an opportunity for the company to enhance its environmental accountability and transparency.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
TomoTherapy Incorporated’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for TomoTherapy Incorporated yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project